TD Asset Management »

Akero Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 125k 25.26
2023-12-31 $2.2M 94k 23.35
2023-09-30 $6.4M 126k 50.58
2023-06-30 $2.9M 63k 46.69
2023-03-31 $2.2M 58k 38.26
2022-12-31 $2.9M 52k 54.80
2022-09-30 $570k 19k 29.81
2021-12-31 $531k 25k 21.15
2021-09-30 $561k 25k 22.35
2021-06-30 $538k 25k 21.43
2021-03-31 $728k 25k 29.00
2020-12-31 $506k 20k 25.81
2020-09-30 $480k 16k 30.76
2020-06-30 $217k 8.7k 24.88
2019-12-31 $229k 10k 22.19
2019-09-30 $235k 10k 22.77